Home / Compliance actions / 671656

FDA Warning Letter — INDELICARE

Case 671656 — FEI 3015204327

The FDA took a Warning Letter action against INDELICARE on Mar 25, 2024 (Lake Forest, CA). The action was issued by CDER and concerns drugs products.

Action Details

Facility
INDELICARE
Date
Mar 25, 2024
Fiscal Year
2024
Product Type
Drugs
Center
CDER
Location
Lake Forest, CA (United States)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.